Literature DB >> 19005418

What is the impact of late-onset cytomegalovirus disease after valganciclovir prophylaxis in kidney transplantation?

Frédéric Lamoth, Oriol Manuel, Jean-Pierre Venetz, Mohamed Faouzi, Pascal Meylan, Manuel Pascual.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19005418     DOI： 10.1097/TP.0b013e3181890788

Source DB:  PubMed          Journal:  Transplantation        ISSN： 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  2 in total

1.  A Markov Analysis of Screening for Late-Onset Cytomegalovirus Disease in Cytomegalovirus High-Risk Kidney Transplant Recipients.

Authors:  Chethan M Puttarajappa; Sundaram Hariharan; Kenneth J Smith
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-12       Impact factor: 8.237

Review 2.  Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis.

Authors:  Siavash Vaziri; Zohre Pezhman; Babak Sayyad; Feizolla Mansouri; Alireza Janbakhsh; Mandana Afsharian; Farid Najafi
Journal:  J Res Med Sci       Date:  2014-12       Impact factor: 1.852
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.